Most Recent Articles by Florence Chaverneff
A panel discussion event held at the US Food and Drug Administration gathered patients with chronic pain and FDA officials, to reconcile concerns around prescriptions of opioid medications with the needs of these patient populations.
The FDA has issued warnings to 3 companies selling kratom-containing products with unsubstantiated claims regarding their effectiveness in conditions that include opioid withdrawal and addiction and chronic pain.
April 28, 2018 is National Prescription Drug Take Back Day.
Keith Humphreys, PhD, who served as senior policy advisor at the White House Office of National Drug Control Policy in the Obama Administration, shared his views on the opioid epidemic.
There has been talk on redefining the statistical significance of the P-Value.